Differential predictive value of baseline tumor size according to PD-L1 expression in advanced NSCLC treated with immune checkpoint inhibitors
{{output}}
Background: The predictive role of baseline tumor size (BTS) in advanced NSCLC treated with immune checkpoint inhibitors (ICIs) is unclear. We investigated its impact on ICI efficacy stratified by PD-L1 expression. ... ...
